These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 23935204)

  • 61. Effect of HIV-1 subtypes on disease progression in rural Uganda: a prospective clinical cohort study.
    Ssemwanga D; Nsubuga RN; Mayanja BN; Lyagoba F; Magambo B; Yirrell D; Van der Paal L; Grosskurth H; Kaleebu P
    PLoS One; 2013; 8(8):e71768. PubMed ID: 23951241
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Long-term perspective on the prevalent-cohort biases in studies of human immunodeficiency virus progression.
    Alcabes P; Pezzotti P; Phillips AN; Rezza G; Vlahov D
    Am J Epidemiol; 1997 Oct; 146(7):543-51. PubMed ID: 9326431
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Increased survival among HIV-1 and HIV-2 dual-infected individuals compared to HIV-1 single-infected individuals.
    Esbjörnsson J; Månsson F; Kvist A; Isberg PE; Biague AJ; da Silva ZJ; Jansson M; Fenyö EM; Norrgren H; Medstrand P
    AIDS; 2014 Apr; 28(7):949-57. PubMed ID: 24812673
    [TBL] [Abstract][Full Text] [Related]  

  • 64. AIDS--beyond helper T cells.
    Knight SC; Patterson S
    Lancet; 1996 Sep; 348(9028):631. PubMed ID: 8782750
    [No Abstract]   [Full Text] [Related]  

  • 65. Is cytomegalovirus infection a co-factor in HIV-1 disease progression?
    Robain M; Boufassa F; Hubert JB; Dussaix E; Sadeg K; Meyer L
    Epidemiol Infect; 2000 Oct; 125(2):415-20. PubMed ID: 11117966
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Epigenetics, N-myrystoyltransferase-1 and casein kinase-2-alpha modulates the increased replication of HIV-1 CRF02_AG, compared to subtype-B viruses.
    Bhargavan B; Kanmogne GD
    Sci Rep; 2019 Jul; 9(1):10689. PubMed ID: 31337802
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The risk of AIDS-defining events is decreasing over time in the German HIV-1 Seroconverter Cohort.
    Altmann M; An der Heiden M; Scheufele R; Hartmann K; Houareau C; Bartmeyer B; Hamouda O;
    BMC Infect Dis; 2012 Apr; 12():94. PubMed ID: 22515400
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Dual HIV infection.
    Cheonis N
    BETA; 2006; 18(2):36-40. PubMed ID: 16610118
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Differential effects of Tat proteins derived from HIV-1 subtypes B and recombinant CRF02_AG on human brain microvascular endothelial cells: implications for blood-brain barrier dysfunction.
    Woollard SM; Bhargavan B; Yu F; Kanmogne GD
    J Cereb Blood Flow Metab; 2014 Jun; 34(6):1047-59. PubMed ID: 24667918
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Variants in ZNRD1 gene predict HIV-1/AIDS disease progression in a Han Chinese population in Taiwan.
    Lin YJ; Lan YC; Hung CH; Lin TH; Huang SM; Liao CC; Lin CW; Lai CH; Tien N; Liu X; Ho MW; Chien WK; Chen JH; Wang JH; Tsai FJ
    PLoS One; 2013; 8(7):e67572. PubMed ID: 23874430
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Short Communication: The Interaction of HIV Set Point Viral Load and Subtype on Disease Progression.
    McPhee E; Grabowski MK; Gray RH; Ndyanabo A; Ssekasanvu J; Kigozi G; Makumbi F; Serwadda D; Quinn TC; Laeyendecker O
    AIDS Res Hum Retroviruses; 2019 Jan; 35(1):49-51. PubMed ID: 30520309
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Superinfection with a heterologous HIV strain per se does not lead to faster progression.
    Fung IC; Gambhir M; van Sighem A; de Wolf F; Garnett GP
    Math Biosci; 2010 Mar; 224(1):1-9. PubMed ID: 19932122
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Estimated global distribution and regional spread of HIV-1 genetic subtypes in the year 2000.
    Osmanov S; Pattou C; Walker N; Schwardländer B; Esparza J;
    J Acquir Immune Defic Syndr; 2002 Feb; 29(2):184-90. PubMed ID: 11832690
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The relationship between HIV seroconversion illness, HIV test interval and time to AIDS in a seroconverter cohort.
    Tyrer F; Walker AS; Gillett J; Porter K;
    Epidemiol Infect; 2003 Dec; 131(3):1117-23. PubMed ID: 14959779
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Multistate recursively imputed survival trees for time-to-event data analysis: an application to AIDS and mortality post-HIV infection data.
    Tapak L; Kosorok MR; Sadeghifar M; Hamidi O
    BMC Med Res Methodol; 2018 Nov; 18(1):129. PubMed ID: 30424736
    [TBL] [Abstract][Full Text] [Related]  

  • 76. HIV/AIDS: waiting for a cure.
    Shearer WT
    J Allergy Clin Immunol; 2008 Jul; 122(1):34-5. PubMed ID: 18547632
    [No Abstract]   [Full Text] [Related]  

  • 77. A joint frailty model provides for risk stratification of human immunodeficiency virus-infected patients based on unobserved heterogeneity.
    Jung TH; Kyriakides T; Holodniy M; Esserman D; Peduzzi P
    J Clin Epidemiol; 2018 Jun; 98():16-23. PubMed ID: 29432857
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Multistage genomewide association study identifies a locus at 1q41 associated with rate of HIV-1 disease progression to clinical AIDS.
    Herbeck JT; Gottlieb GS; Winkler CA; Nelson GW; An P; Maust BS; Wong KG; Troyer JL; Goedert JJ; Kessing BD; Detels R; Wolinsky SM; Martinson J; Buchbinder S; Kirk GD; Jacobson LP; Margolick JB; Kaslow RA; O'Brien SJ; Mullins JI
    J Infect Dis; 2010 Feb; 201(4):618-26. PubMed ID: 20064070
    [TBL] [Abstract][Full Text] [Related]  

  • 79. HIV genetic diversity: biological and public health consequences.
    Butler IF; Pandrea I; Marx PA; Apetrei C
    Curr HIV Res; 2007 Jan; 5(1):23-45. PubMed ID: 17266555
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.